DarioHealth to Host Third Quarter Conference Call on November 14, 2017

    Earnings and Business Update Conference Call Scheduled for 9:00am ET

    Nov 6, 2017

    CAESAREA, Israel, Nov 6, 2017, /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will release its third quarter 2017 results on Tuesday, November 14 and host a conference call at 9:00am ET. The Company will discuss its third quarter 2017 operating and financial results and its strategy and outlook for the remainder of 2017 and 2018. The conference call will be hosted by Erez Raphael, Chief Executive Officer, and Zvi Ben-David, Chief Financial Officer. The live conference call can be accessed by dialing (888) 567-1603 or (404) 267-0368. Participants should ask for the DarioHealth Earnings Conference Call. The conference call will also be available via live webcast at: http://www.investorcalendar.com/event/22493

    DarioHealth Logo

    Conference Call Details:

    Date: Tuesday, November 14, 2017

    Time: 9:00AM ET

    Dial-in Number: (888) 567-1603

    International Dial-in Number: (404) 267-0368

    Webcast: http://www.investorcalendar.com/event/22493

    Participants are recommended to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through February 14, 2018. To listen to the replay, dial (877) 481-4010 (domestic) or (919) 882-2331 (international) and use replay ID 22493. The webcast replay will be available through February 14, 2018.

    About DarioHealth Corp.

    DarioHealth Corp. is a leading global digital health company serving tens of thousands of users with dynamic mobile health solutions. We believe people deserve the best tools to manage their treatment, and harnessing big data, we have developed a unique way for our users to analyze and personalize their diabetes management. With our smart diabetes solution, users have direct access to track and monitor all facets of diabetes, without having the disease slow them down. The acclaimed Dario™ Blood Glucose Monitoring System all-in-one blood glucose meter and native smartphone app gives users an unrivaled method for self-diabetes management. DarioHealth is headquartered in Caesarea, Israel with a regional office in Burlington, Massachusetts. For more information, visit http://mydario.investorroom.com/.

    DarioHealth Corporate Contact:
    Shmuel Herschberg,
    Marketing Director,
    shmuel@mydario.com,
    +1-914-775-5548

    DarioHealth Public Relations Contact:
    Terese Kelly,
    Rosica PR,
    terese@rosica.com,
    +1-201-843-5600

    DarioHealth Investor Relations Contact:
    Stephen Hart,
    Hayden IR,
    DRIO@HaydenIR.com,
    +1-917-658-7878

     

    SOURCE DarioHealth Corp.


    print email rss